Regulatory Updates
Sep 15, 2026•1 min read
Epic Pharma receives FDA approval for Tizanidine Hydrochloride tablets (ANDA076347)
Epic Pharma LLC's ANDA076347 for prescription oral tablets of Tizanidine Hydrochloride (2 mg and 4 mg) has been approved by the FDA, with labeling submissions approved between 2007 and 2016.
Regulatory Updates
Aug 30, 2026•1 min read
Epic Pharma LLC Submits ANDA078975 for Topical Ciclopirox 8% Solution (Discontinued)
Epic Pharma LLC filed ANDA078975 for a discontinued topical ciclopirox 8% solution; FDA records show the original submission was approved on 2010-02-17.